Vault-13

PFM Health Sciences, LP

SAN FRANCISCO, CA · CIK 1442756 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2008 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
San Francisco, CA (main office)United States United Statesabout 5
New York, NY2 officesUnited States United States2

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.2bn reported value +21.2% vs Q1 2026
96positions
34.3%in top 10
33 new 22 added 41 reduced 14 sold out vs Q1 2026

Options: 1 call positions ($8.0m notional), 1 put positions ($5.7m notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ASCENDIS PHARMA A/S ORD SHS ASND ASND 233,171 $62.2m5.40% 5.40% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 233.2k
2 AXSOME THERAPEUTICS INC COM AXSM AXSM 219,596 $53.8m4.67% 4.67% ReducedShares held: Q3 2025 530.3k, Q4 2025 251.6k, Q1 2026 264.3k, Q2 2026 219.6k -44.7k -44,708 -16.9%
3 ELI LILLY & CO COM LLY LLY 39,258 $47.1m4.09% 4.09% ReducedShares held: Q3 2025 225.1k, Q4 2025 68.3k, Q1 2026 65.8k, Q2 2026 39.3k -26.5k -26,504 -40.3%
4 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 160,768 $38.7m3.36% 3.36% ReducedShares held: Q3 2025 0, Q4 2025 50.5k, Q1 2026 178.1k, Q2 2026 160.8k -17.4k -17,376 -9.8%
5 HUMANA INC COM HUM HUM 94,375 $37.5m3.25% 3.25% NewShares held: Q3 2025 3.6k, Q4 2025 0, Q1 2026 0, Q2 2026 94.4k
6 UNITEDHEALTH GROUP INC COM UNH UNH 88,276 $36.7m3.19% 3.19% AddedShares held: Q3 2025 0, Q4 2025 50.5k, Q1 2026 58.0k, Q2 2026 88.3k +30.2k +30,238 52.1%
7 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 213,407 $36.0m3.12% 3.12% ReducedShares held: Q3 2025 57.2k, Q4 2025 163.2k, Q1 2026 215.7k, Q2 2026 213.4k -2.3k -2,271 -1.1%
8 INHIBRX BIOSCIENCES INC COM INBX INBX 308,385 $29.2m2.54% 2.54% AddedShares held: Q3 2025 239.6k, Q4 2025 265.5k, Q1 2026 305.4k, Q2 2026 308.4k +3.0k +2,954 1.0%
9 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 49,991 $27.1m2.35% 2.35% AddedShares held: Q3 2025 95.7k, Q4 2025 67.7k, Q1 2026 39.8k, Q2 2026 50.0k +10.2k +10,186 25.6%
10 REVOLUTION MEDICINES INC COM RVMD RVMD 143,222 $26.8m2.33% 2.33% AddedShares held: Q3 2025 331.1k, Q4 2025 151.5k, Q1 2026 140.8k, Q2 2026 143.2k +2.5k +2,452 1.7%
11 ICON PLC SHS ICLR ICLR 136,482 $23.7m2.06% 2.06% AddedShares held: Q3 2025 133.7k, Q4 2025 115.3k, Q1 2026 57.5k, Q2 2026 136.5k +79.0k +78,982 137.4%
12 TENET HEALTHCARE CORP COM NEW THC THC 126,572 $23.7m2.06% 2.06% ReducedShares held: Q3 2025 461.7k, Q4 2025 397.8k, Q1 2026 398.6k, Q2 2026 126.6k -272.0k -271,995 -68.2%
13 EDWARDS LIFESCIENCES CORP COM EW EW 250,453 $22.7m1.97% 1.97% ReducedShares held: Q3 2025 381.3k, Q4 2025 246.8k, Q1 2026 254.5k, Q2 2026 250.5k -4.1k -4,057 -1.6%
14 WATERS CORP COM WAT WAT 59,825 $22.4m1.95% 1.95% AddedShares held: Q3 2025 30.8k, Q4 2025 43.2k, Q1 2026 39.8k, Q2 2026 59.8k +20.1k +20,062 50.5%
15 PENUMBRA INC COM PEN PEN 60,221 $19.0m1.65% 1.65% ReducedShares held: Q3 2025 195.1k, Q4 2025 145.2k, Q1 2026 139.8k, Q2 2026 60.2k -79.6k -79,558 -56.9%
16 BRIDGEBIO PHARMA INC COM BBIO BBIO 253,358 $18.9m1.64% 1.64% ReducedShares held: Q3 2025 327.2k, Q4 2025 306.5k, Q1 2026 257.7k, Q2 2026 253.4k -4.4k -4,389 -1.7%
17 STRYKER CORPORATION COM SYK SYK 56,637 $17.8m1.55% 1.55% AddedShares held: Q3 2025 0, Q4 2025 50.9k, Q1 2026 22.0k, Q2 2026 56.6k +34.7k +34,680 157.9%
18 METTLER TOLEDO INTERNATIONAL COM MTD MTD 13,344 $17.0m1.48% 1.48% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 13.3k
19 INDIVIOR PHARMACEUTICALS INC COM INDV INDV 401,208 $16.5m1.43% 1.43% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 574.7k, Q2 2026 401.2k -173.5k -173,458 -30.2%
20 MERCK & CO INC COM MRK MRK 127,118 $16.3m1.42% 1.42% NewShares held: Q3 2025 236.5k, Q4 2025 187.8k, Q1 2026 0, Q2 2026 127.1k
21 CYTOKINETICS INC COM NEW CYTK CYTK 191,686 $16.3m1.42% 1.42% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 191.7k
22 LANTHEUS HLDGS INC COM LNTH LNTH 146,403 $16.2m1.41% 1.41% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 146.4k
23 CENTENE CORP DEL COM CNC CNC 248,867 $16.0m1.39% 1.39% ReducedShares held: Q3 2025 574.4k, Q4 2025 725.4k, Q1 2026 263.5k, Q2 2026 248.9k -14.6k -14,619 -5.5%
24 COOPER COS INC COM COO COO 220,890 $15.8m1.38% 1.38% AddedShares held: Q3 2025 74.4k, Q4 2025 100.8k, Q1 2026 169.8k, Q2 2026 220.9k +51.1k +51,061 30.1%
25 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 29,313 $15.7m1.37% 1.37% ReducedShares held: Q3 2025 0, Q4 2025 7.3k, Q1 2026 34.1k, Q2 2026 29.3k -4.8k -4,833 -14.2%
26 ACADIA HEALTHCARE COMPANY IN COM ACHC ACHC 524,934 $15.5m1.35% 1.35% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 582.7k, Q2 2026 524.9k -57.8k -57,811 -9.9%
27 ORUKA THERAPEUTICS INC COM ORKA ORKA 158,825 $15.1m1.31% 1.31% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 174.1k, Q2 2026 158.8k -15.2k -15,227 -8.8%
28 OSCAR HEALTH INC CL A OSCR OSCR 519,016 $14.8m1.29% 1.29% AddedShares held: Q3 2025 820.6k, Q4 2025 499.8k, Q1 2026 499.8k, Q2 2026 519.0k +19.2k +19,179 3.8%
29 THERMO FISHER SCIENTIFIC INC COM TMO TMO 28,496 $14.3m1.24% 1.24% AddedShares held: Q3 2025 2.3k, Q4 2025 37.9k, Q1 2026 14.8k, Q2 2026 28.5k +13.7k +13,664 92.1%
30 CVS HEALTH CORP COM CVS CVS 137,457 $14.2m1.23% 1.23% NewShares held: Q3 2025 346.7k, Q4 2025 107.8k, Q1 2026 0, Q2 2026 137.5k
31 MERIT MED SYS INC COM MMSI MMSI 197,038 $13.7m1.19% 1.19% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 162.5k, Q2 2026 197.0k +34.6k +34,569 21.3%
32 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 38,575 $12.9m1.12% 1.12% AddedShares held: Q3 2025 60.6k, Q4 2025 31.2k, Q1 2026 35.4k, Q2 2026 38.6k +3.1k +3,137 8.8%
33 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 342,751 $12.8m1.11% 1.11% AddedShares held: Q3 2025 0, Q4 2025 133.2k, Q1 2026 325.0k, Q2 2026 342.8k +17.8k +17,794 5.5%
34 NOVO-NORDISK A S ADR NVO NVO 265,016 $12.7m1.10% 1.10% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 197.2k, Q2 2026 265.0k +67.8k +67,835 34.4%
35 INTEGER HLDGS CORP COM ITGR ITGR 126,669 $11.8m1.03% 1.03% ReducedShares held: Q3 2025 0, Q4 2025 106.6k, Q1 2026 135.1k, Q2 2026 126.7k -8.4k -8,412 -6.2%
36 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 121,222 $11.8m1.03% 1.03% ReducedShares held: Q3 2025 67.8k, Q4 2025 99.6k, Q1 2026 172.1k, Q2 2026 121.2k -50.9k -50,915 -29.6%
37 DEFINIUM THERAPEUTICS INC COM SHS DFTX DFTX 249,020 $11.7m1.02% 1.02% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 205.3k, Q2 2026 249.0k +43.7k +43,703 21.3%
38 GILEAD SCIENCES INC COM GILD GILD 90,858 $11.5m1.00% 1.00% NewShares held: Q3 2025 0, Q4 2025 71.0k, Q1 2026 0, Q2 2026 90.9k
39 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 101,550 $11.3m0.98% 0.98% ReducedShares held: Q3 2025 48.2k, Q4 2025 40.2k, Q1 2026 136.6k, Q2 2026 101.5k -35.1k -35,071 -25.7%
40 HENRY SCHEIN INC COM HSIC HSIC 134,423 $11.2m0.97% 0.97% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 153.1k, Q2 2026 134.4k -18.7k -18,691 -12.2%
41 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 131,667 $10.7m0.93% 0.93% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 64.3k, Q2 2026 131.7k +67.4k +67,388 104.8%
42 TANGO THERAPEUTICS INC COM TNGX TNGX 326,047 $10.2m0.88% 0.88% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 406.2k, Q2 2026 326.0k -80.2k -80,198 -19.7%
43 TELEFLEX INCORPORATED COM TFX TFX 79,708 $10.1m0.88% 0.88% NewShares held: Q3 2025 0, Q4 2025 102.4k, Q1 2026 0, Q2 2026 79.7k
44 VIKING THERAPEUTICS INC COM VKTX VKTX 255,330 $10.0m0.86% 0.86% ReducedShares held: Q3 2025 183.5k, Q4 2025 189.0k, Q1 2026 263.1k, Q2 2026 255.3k -7.8k -7,776 -3.0%
45 BRIGHTSPRING HEALTH SVCS INC COM BTSG BTSG 141,914 $9.9m0.86% 0.86% ReducedShares held: Q3 2025 0, Q4 2025 118.5k, Q1 2026 187.3k, Q2 2026 141.9k -45.4k -45,421 -24.2%
46 VERA THERAPEUTICS INC CL A VERA VERA 224,289 $9.6m0.84% 0.84% AddedShares held: Q3 2025 513.7k, Q4 2025 107.7k, Q1 2026 174.9k, Q2 2026 224.3k +49.4k +49,422 28.3%
47 ROIVANT SCIENCES LTD SHS ROIV ROIV 268,008 $9.5m0.82% 0.82% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 207.4k, Q2 2026 268.0k +60.6k +60,562 29.2%
48 CG ONCOLOGY INC COM CGON CGON 128,286 $9.1m0.79% 0.79% ReducedShares held: Q3 2025 157.9k, Q4 2025 164.0k, Q1 2026 165.9k, Q2 2026 128.3k -37.6k -37,639 -22.7%
49 AMNEAL PHARMACEUTICALS INC COM STK CL A AMRX AMRX 480,715 $8.3m0.72% 0.72% ReducedShares held: Q3 2025 355.8k, Q4 2025 1.5m, Q1 2026 930.1k, Q2 2026 480.7k -449.4k -449,381 -48.3%
50 EUPRAXIA PHARMACEUTICALS INC COM EPRX EPRX 1,210,661 $8.0m0.69% 0.69% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 540.9k, Q2 2026 1.2m +669.8k +669,790 123.8%
51 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 65,196 $7.8m0.67% 0.67% NewShares held: Q3 2025 65.0k, Q4 2025 0, Q1 2026 0, Q2 2026 65.2k
52 KODIAK SCIENCES INC COM KOD KOD 193,315 $7.5m0.65% 0.65% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 114.7k, Q2 2026 193.3k +78.6k +78,596 68.5%
53 ABBOTT LABS COM ABT ABT 82,230 $7.5m0.65% 0.65% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 140.4k, Q2 2026 82.2k -58.2k -58,202 -41.4%
54 WEST PHARMACEUTICAL SVSC INC COM WST WST 20,733 $7.4m0.65% 0.65% NewShares held: Q3 2025 18.4k, Q4 2025 0, Q1 2026 0, Q2 2026 20.7k
55 TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS TAK TAK 444,173 $7.1m0.62% 0.62% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 444.2k
56 HINGE HEALTH INC CL A HNGE HNGE 82,860 $6.9m0.60% 0.60% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 82.9k
57 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 242,069 $6.3m0.55% 0.55% NewShares held: Q3 2025 360.5k, Q4 2025 0, Q1 2026 0, Q2 2026 242.1k
58 INTEGRA LIFESCIENCES HLDGS C COM NEW IART IART 348,746 $6.3m0.54% 0.54% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 348.7k
59 ILLUMINA INC COM ILMN ILMN 35,040 $6.2m0.53% 0.53% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 28.9k, Q2 2026 35.0k +6.2k +6,171 21.4%
60 MEIRAGTX HLDGS PLC COM MGTX MGTX 455,286 $6.2m0.53% 0.53% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 455.3k
61 OCULIS HOLDING AG ORDINARY SHARES OCS OCS 436,042 $6.0m0.53% 0.53% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 436.0k
62 NATERA INC COM NTRA NTRA 22,077 $6.0m0.52% 0.52% ReducedShares held: Q3 2025 115.6k, Q4 2025 0, Q1 2026 60.0k, Q2 2026 22.1k -37.9k -37,927 -63.2%
63 ABIVAX SA SPONSORED ADS ABVX ABVX 43,264 $5.8m0.50% 0.50% AddedShares held: Q3 2025 0, Q4 2025 31.9k, Q1 2026 26.7k, Q2 2026 43.3k +16.6k +16,600 62.3%
64 GUARDANT HEALTH INC COM GH GH 36,701 $5.5m0.48% 0.48% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 36.7k
65 CELCUITY INC COM CELC CELC 52,155 $5.5m0.47% 0.47% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 52.2k
66 BELITE BIO INC SPONSORED ADS BLTE BLTE 34,803 $5.4m0.47% 0.47% ReducedShares held: Q3 2025 0, Q4 2025 19.8k, Q1 2026 59.4k, Q2 2026 34.8k -24.6k -24,629 -41.4%
67 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 91,550 $4.9m0.43% 0.43% ReducedShares held: Q3 2025 115.1k, Q4 2025 68.2k, Q1 2026 126.4k, Q2 2026 91.5k -34.8k -34,833 -27.6%
68 ARCUS BIOSCIENCES INC COM RCUS RCUS 152,129 $4.7m0.41% 0.41% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 152.1k
69 CHARLES RIV LABS INTL INC COM CRL CRL 18,747 $4.3m0.37% 0.37% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 18.7k
70 ELANCO ANIMAL HEALTH INC COM ELAN ELAN 172,489 $4.2m0.37% 0.37% NewShares held: Q3 2025 0, Q4 2025 207.3k, Q1 2026 0, Q2 2026 172.5k
71 ARGENX SE SPONSORED ADR ARGX ARGX 4,482 $4.2m0.36% 0.36% ReducedShares held: Q3 2025 6.4k, Q4 2025 4.2k, Q1 2026 4.5k, Q2 2026 4.5k -53 -53 -1.2%
72 BIO RAD LABS INC CL A BIO BIO 13,995 $4.1m0.36% 0.36% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 14.0k
73 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 46,217 $4.1m0.36% 0.36% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 46.2k
74 MBX BIOSCIENCES INC COM MBX MBX 70,971 $3.9m0.34% 0.34% ReducedShares held: Q3 2025 221.5k, Q4 2025 79.3k, Q1 2026 71.9k, Q2 2026 71.0k -923 -923 -1.3%
75 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 31,536 $3.7m0.32% 0.32% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 31.5k
76 CULLINAN THERAPEUTICS INC COM CGEM CGEM 192,442 $3.5m0.30% 0.30% ReducedShares held: Q3 2025 0, Q4 2025 227.0k, Q1 2026 227.4k, Q2 2026 192.4k -35.0k -34,964 -15.4%
77 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 247,589 $3.5m0.30% 0.30% ReducedShares held: Q3 2025 1.7m, Q4 2025 779.6k, Q1 2026 1.4m, Q2 2026 247.6k -1.1m -1,119,510 -81.9%
78 HCA HEALTHCARE INC COM HCA HCA 8,295 $3.2m0.28% 0.28% ReducedShares held: Q3 2025 65.8k, Q4 2025 13.9k, Q1 2026 13.4k, Q2 2026 8.3k -5.1k -5,056 -37.9%
79 CAPRICOR THERAPEUTICS INC COM NEW CAPR CAPR 122,221 $2.9m0.26% 0.26% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 123.8k, Q2 2026 122.2k -1.6k -1,610 -1.3%
80 DENALI THERAPEUTICS INC COM DNLI DNLI 100,966 $2.6m0.23% 0.23% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 101.0k
81 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 118,422 $2.6m0.22% 0.22% ReducedShares held: Q3 2025 256.5k, Q4 2025 243.0k, Q1 2026 245.0k, Q2 2026 118.4k -126.6k -126,599 -51.7%
82 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 143,700 $2.6m0.22% 0.22% ReducedShares held: Q3 2025 436.2k, Q4 2025 134.5k, Q1 2026 145.3k, Q2 2026 143.7k -1.6k -1,575 -1.1%
83 TARSUS PHARMACEUTICALS INC COM TARS TARS 40,579 $2.6m0.22% 0.22% ReducedShares held: Q3 2025 0, Q4 2025 27.3k, Q1 2026 80.2k, Q2 2026 40.6k -39.6k -39,647 -49.4%
84 OUTSET MED INC COM NEW OM OM 582,122 $2.5m0.22% 0.22% ReducedShares held: Q3 2025 1.7m, Q4 2025 530.8k, Q1 2026 594.6k, Q2 2026 582.1k -12.5k -12,508 -2.1%
85 OMADA HEALTH INC COM OMDA OMDA 114,442 $2.5m0.22% 0.22% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 114.4k
86 ERASCA INC COM ERAS ERAS 134,088 $2.5m0.21% 0.21% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 134.1k
87 CENCORA INC COM COR COR 7,385 $2.1m0.18% 0.18% NewShares held: Q3 2025 80.5k, Q4 2025 0, Q1 2026 0, Q2 2026 7.4k
88 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 207,357 $2.1m0.18% 0.18% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 207.4k
89 OMNICELL COM COM OMCL OMCL 49,040 $2.0m0.18% 0.18% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 49.0k
90 CVRX INC COM CVRX CVRX 369,572 $1.9m0.16% 0.16% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 369.6k
91 HIMS & HERS HEALTH INC COM CL A HIMS HIMS 49,454 $1.7m0.15% 0.15% NewShares held: Q3 2025 22.9k, Q4 2025 0, Q1 2026 0, Q2 2026 49.5k
92 MINERALYS THERAPEUTICS INC COM MLYS MLYS 62,418 $1.7m0.15% 0.15% ReducedShares held: Q3 2025 0, Q4 2025 47.6k, Q1 2026 142.7k, Q2 2026 62.4k -80.3k -80,259 -56.2%
93 TECTONIC THERAPEUTIC INC COM TECX TECX 45,631 $1.6m0.14% 0.14% ReducedShares held: Q3 2025 0, Q4 2025 42.7k, Q1 2026 46.1k, Q2 2026 45.6k -498 -498 -1.1%
94 UNIQURE NV SHS QURE QURE 26,396 $1.2m0.11% 0.11% ReducedShares held: Q3 2025 46.4k, Q4 2025 39.5k, Q1 2026 42.6k, Q2 2026 26.4k -16.2k -16,239 -38.1%
95 REZOLUTE INC COM NEW RZLT RZLT 127,289 $661.9k0.06% 0.06% ReducedShares held: Q3 2025 452.7k, Q4 2025 206.3k, Q1 2026 128.7k, Q2 2026 127.3k -1.4k -1,437 -1.1%
96 CARIBOU BIOSCIENCES INC COM CRBU CRBU 354,687 $624.2k0.05% 0.05% ReducedShares held: Q3 2025 1.4m, Q4 2025 957.8k, Q1 2026 957.8k, Q2 2026 354.7k -603.1k -603,100 -63.0%

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
ASCENDIS PHARMA A/S 152,034 $34.8m152.0k shares
GLAUKOS CORP GKOS GKOS 215,685 $23.2m215.7k shares
CENTESSA PHARMACEUTICALS PLC 528,224 $21.0m528.2k shares
ASCENDIS PHARMA A/S ASND 2.25 04.01.28 ASND 2.25 04.01.28 11,505,000 $16.9m11.5m shares
NEOGENOMICS INC NEO NEO 1,784,552 $13.2m1.8m shares
DEXCOM INC DXCM DXCM 149,734 $9.4m149.7k shares
TERNS PHARMACEUTICALS INC 172,962 $9.1m173.0k shares
SOLENO THERAPEUTICS INC SLNO SLNO 248,180 $8.3m248.2k shares
BILLIONTOONE INC BLLN BLLN 88,069 $7.0m88.1k shares
CARDINAL HEALTH INC CAH CAH 31,941 $6.7m31.9k shares
ALIGNMENT HEALTHCARE INC ALHC ALHC 359,826 $6.3m359.8k shares
PERSONALIS INC PSNL PSNL 870,097 $5.5m870.1k shares
MEDLINE INC MDLN MDLN 86,777 $3.9m86.8k shares
GLOBUS MED INC GMED GMED 16,923 $1.5m16.9k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
CENCORA INC COR · Call CORCall 28,100 $8.0m28.1k shares New
CENTENE CORP DEL CNC · Put CNCPut 88,200 $5.7m88.2k shares New